Spire Healthcare Group

UK Healthcare Expansion And Digital Transformation Will Redefine Care

AnalystConsensusTarget

Not Invested

Based on Analyst Price Targets

Published

09 Feb 25

Updated

01 May 25

n/a

AnalystConsensusTarget's Fair Value

n/a

-21.0%

-23.2%

-21.0%

-23.2%

You can edit this narrative until May 12 5:58 AM. Then, changes will post as Updates.

Author's Valuation

UK£2.9139.5% undervalued

AnalystConsensusTarget Fair Value

Narrative

Updates8

Shared on 01 May 25

Shared on 23 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 17 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 09 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 02 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 26 Mar 25

Fair value Decreased 0.68%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 19 Mar 25

Fair value Decreased 2.66%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 12 Mar 25

Fair value Increased 4.83%

AnalystConsensusTarget has increased discount rate from 7.8% to 9.0%.

AnalystConsensusTarget Fair Value

UK£2.91

39.5% undervalued

Future estimation in

% p.a.

Decrease

Increase

Current revenue growth rate

5.05%

Healthcare Services revenue growth rate

0.23%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

Decrease

Increase

Current discount rate

8.87%

Calculation

UK£85.23m

Earnings '28

17.11x

PE Ratio '28

UK£1.46b

Market Cap '28

UK£1.46b

Market Cap '28

395.28m

No. shares '28

UK£3.69

Share Price '28

UK£3.69 Share Price '28

Discounted to 2025 @ 8.07% p.a.

UK£2.92

Fair Value '25